3M Co. on Friday closed the $6.7 billion purchase of wound care firm Acelity Inc., the largest acquisition in 3M's history.
3M closes $6.7 billion purchase of wound care products firm Acelity
October 12, 2019 at 12:19AM
The deal, which includes the assumption of $2.4 billion in debt, gives Maplewood-based 3M a business that is well regarded for advanced wound care dressings and therapies.
3M bought San Antonio-based Acelity and its KCI wound care subsidiaries from its investor owners: Apax Partners, Canada Pension Plan Investment Board and the Public Sector Pension Investment Board.
While Wall Street analysts noted that the price is a bit steep, 3M executives said Acelity brings unique technologies, 3,000 patients, 4,500 global employees and 2018 revenue of $1.5 billion. Its sales have been growing about 5% a year.
"This is an exciting day as we bring together two premier and innovative companies that are focused on delivering comprehensive health care solutions to enable better outcomes for patients," 3M CEO Mike Roman said in a statement.
He said the acquisition fits well with 3M's goal of increasing the size of what used to be a $6 billion health care business. 3M's medical solutions business has traditionally sold wound dressings, medical tapes, sterilization products and patient warming devices such as the Bair Hugger.
3M's stock price rose 3.8%, or $5.79, to close at $158.10 Friday.
Dee DePass
about the writer
The InPen app paves the way for the launch of the company’s “Smart MDI” system combining a smart insulin pen that tracks doses and a monitor that makes real-time glucose readings for people who make multiple daily injections.
